Table 2 Baseline characteristics in AMI patients according to HbA _1c level

n

111

75

Age (years)

66.0 ± 5.1

68.6 ± 6.2

0.002

Males

67 (60.4)

49 (65.3)

0.492

Risk factors

  Diabetes

49 (44.1)

52 (69.3)

0.001

  Previous CAD

30 (27.0)

28 (37.3)

0.137

  Smoking

41 (36.9)

33 (44.0)

0.334

  BMI (kg/m²)

26.3 ± 2.8

26.5 ± 3.0

0.556

  SBP (mmHg)

126 ± 18

128 ± 21

0.435

  DBP (mmHg)

76 ± 10

77 ± 13

0.720

  HR (bpm)

70 ± 11

72 ± 13

0.234

  LVEF (%)

57.8 ± 11.6

53.2 ± 11.9

0.010

  eGFR (ml/min/1.73 m²)

70.6 ± 31.8

63.2 ± 25.7

0.061

  TC (mmol/L)

4.45 ± 0.97

4.67 ± 1.15

0.167

  TG (mmol/L)

1.96 ± 1.00

2.34 ± 1.68

0.056

  FBG (mmol/L)

6.58 ± 1.73

9.12 ± 2.63

< 0.001

  MAGE (mmol/L)

2.64 ± 1.23

4.15 ± 1.28

< 0.001

Medications

  Aspirin

101 (91.0)

72 (96.0)

0.189

  Beta-blocker

46 (41.4)

32 (42.7)

0.868

  Oral anti-hyperglycemic

24 (21.6)

43 (57.3)

< 0.001

  Insulin

17 (15.3)

46 (61.3)

< 0.001

  ACEI

51 (45.9)

36 (48.0)

0.783

  Statin

85 (76.6)

61 (81.3)

0.439

  Diuretic

13 (11.7)

24 (32.0)

0.001

Type of AMI

  STEMI

74 (66.7)

60 (80.0)

0.047

  Non-STEMI

37 (33.3)

15 (20.0)

0.047

GRACE Score

137 ± 32

151 ± 36

0.005